Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
41
2025
Q4
Hold
0
36
2025
Q3
Hold
0
36
2025
Q2
Hold
0
40
2025
Q1
Hold
0
39
2024
Q4
Hold
0
35
2024
Q3
Hold
0
38
2024
Q2
Hold
0
39
2024
Q1
Hold
0
28
2023
Q4
Hold
0
34
2023
Q3
Hold
0
28
2023
Q2
Hold
0
43
2023
Q1
Hold
0
40
2022
Q4
Hold
0
22
2022
Q3
Hold
0
25
2022
Q2
Hold
0
23
2022
Q1
Sell
-18,500
Closed -$1.25M 23
2021
Q4
$1.14M Buy
+18,500
New +$1.16M 1% 34

Other funds holding MET

TCM Advisors's MET Position: Q1 2026 in Review

TCM Advisors held its MetLife (MET) position steady in Q1 2026 at 0 shares worth $735K. The position accounts for 0.05% of the portfolio, ranked #41.

TCM Advisors first reported a position in MET in Q4 2021 and has held it in 1 quarter since. The position peaked at $1.14M in Q4 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • TCM Advisors held 0 shares of MetLife worth $735K as of Q1 2026.
  • TCM Advisors left its MetLife share count unchanged in Q1 2026.
  • MetLife made up 0.05% of TCM Advisors's portfolio in Q1 2026, its #41 holding.
  • TCM Advisors first reported a position in MetLife in Q4 2021 and has held it in 1 quarter since.
  • TCM Advisors's MetLife position peaked at $1.14M in Q4 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on TCM Advisors's 13F filing for Q1 2026, filed 14 May 2026.